UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 299

Sortiert nach

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2019-05, Vol.90 (5), p.514

2019

Volltextzugriff (PDF)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant

Frontiers in immunology, 2018-03, Vol.9, p.410-410

2018

Volltextzugriff (PDF)

From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis

Clinical & translational immunology, 2023, Vol.12 (2), p.e1437-n/a

2023

Volltextzugriff (PDF)

Spirit As a Separate Dimension of Human Nature: Relevance to Psychotherapy

Pastoral psychology, 2022-08, Vol.71 (4), p.511-524

2022

Volltextzugriff (PDF)

Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation

Frontiers in immunology, 2022-01, Vol.12, p.782935-782935

2022

Volltextzugriff (PDF)

Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis

Multiple sclerosis, 2021-11, Vol.27 (13), p.2112-2115

2021

Volltextzugriff (PDF)

Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis

Frontiers in immunology, 2022-02, Vol.13, p.798300-798300

2022

Volltextzugriff (PDF)

Sustained immunotolerance in multiple sclerosis after stem cell transplant

Annals of clinical and translational neurology, 2022-02, Vol.9 (2), p.206-220

2022

Volltextzugriff (PDF)

Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome

Annals of allergy, asthma, & immunology, 2017-06, Vol.118 (6), p.726-728

2017

Volltextzugriff (PDF)

Posterior reversible encephalopathy syndrome (PRES) with sub-arachnoid haemorrhage after bevacizumab and 5-FU

Journal of clinical neuroscience, 2017-06, Vol.40, p.57-59

Massey, Jennifer

2017

Volltextzugriff (PDF)

IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies

Neurology : neuroimmunology & neuroinflammation, 2017-05, Vol.4 (3), p.e341-e341

Massey, Jennifer

2017

Volltextzugriff (PDF)

Eco-campus: applying the ecocity model to develop green university and college campuses

International journal of sustainability in higher education, 2012-01, Vol.13 (2), p.150-165

2012

Volltextzugriff (PDF)

Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant

Cytotherapy (Oxford, England), 2023-12, Vol.25 (12), p.1271-1276

2023

Volltextzugriff (PDF)

Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis

Clinical immunology (Orlando, Fla.), 2023-09, Vol.254, p.109709-109709, Article 109709

2023

Volltextzugriff (PDF)

ASCIA-P76: SULPHASALAZINE-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) ASSOCIATED WITH NECROTISING EOSINOPHILIC MYOSITIS - A NOVEL FINDING

Internal medicine journal, 2016-09, Vol.46 (S4), p.28-28

2016

Volltextzugriff (PDF)

5 AHSCT as immune reconstitution therapy for MS – resetting the immune system or depleting EBV reservoirs?

BMJ neurology open, 2023-08, Vol.5 (Suppl 1), p.A2-A2

2023

Volltextzugriff (PDF)

13 Autologous haematopoietic Stem cell transplantation for non-MS neuroimmunological disorders: a single centre experience

BMJ neurology open, 2023-08, Vol.5 (Suppl 1), p.A6-A6

2023

Volltextzugriff (PDF)

Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review

Multiple sclerosis and related disorders, 2024-06, Vol.86, p.105605, Article 105605

2024

Volltextzugriff (PDF)

Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis

Multiple sclerosis and related disorders, 2019-02, Vol.28, p.31-33

2019

Volltextzugriff (PDF)

B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis

Multiple sclerosis and related disorders, 2019-10, Vol.35, p.100-103

2019

Volltextzugriff (PDF)

Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis

BMJ case reports, 2017-12, Vol.2017, p.bcr-2017-223016

2017

Volltextzugriff (PDF)

First Nations, Métis and Inuit presence in the Newfoundland and Labrador curriculum

Race, ethnicity and education, 2017-07, Vol.20 (4), p.446-462

2017

Volltextzugriff (PDF)

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease

Journal of neurology, neurosurgery and psychiatry, 2024-06, Vol.95 (6), p.544

2024

Volltextzugriff (PDF)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) — a Phase II Clinical Trial

Blood, 2017-12, Vol.130, p.4553-4553

2017

Volltextzugriff (PDF)

1 – 25 von 299

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(268)
Mit Volltextzugriff
(274)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant

From bedside to bench: how existing therapies inform the relationship between Epstein–Barr virus and multiple sclerosis

Spirit As a Separate Dimension of Human Nature: Relevance to Psychotherapy

Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation

Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis

Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis

Sustained immunotolerance in multiple sclerosis after stem cell transplant

Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome

Posterior reversible encephalopathy syndrome (PRES) with sub-arachnoid haemorrhage after bevacizumab and 5-FU

IgG4-related hypertrophic pachymeningitis coexpressing antineutrophil cytoplasmic antibodies

Eco-campus: applying the ecocity model to develop green university and college campuses

Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant

Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis

ASCIA-P76: SULPHASALAZINE-INDUCED DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) ASSOCIATED WITH NECROTISING EOSINOPHILIC MYOSITIS - A NOVEL FINDING

5 AHSCT as immune reconstitution therapy for MS – resetting the immune system or depleting EBV reservoirs?

13 Autologous haematopoietic Stem cell transplantation for non-MS neuroimmunological disorders: a single centre experience

Switching from natalizumab to an anti-CD20 monoclonal antibody in relapsing remitting multiple sclerosis: A systematic review

Autoimmune encephalitis following alemtuzumab treatment of multiple sclerosis

B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple Sclerosis

Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis

First Nations, Métis and Inuit presence in the Newfoundland and Labrador curriculum

Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation

The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease

Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) — a Phase II Clinical Trial

Suchergebnisse filtern